A Study to Observe Treatment Patterns and Outcomes in Participants in Saudi Arabia With Human Epidermal Growth Factor Receptor 2 (HER2-Positive) Unresectable Locally Advanced or Metastatic Breast Cancer (LA/mBC)
Clinical trial NCT02611310 · TERMINATED
Trial details
- NCT number
- NCT02611310
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-19
- Primary completion
- 2018-11-12
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.